List of Tables
    Table 1. Human Insulin Delivery System CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Human Insulin Delivery System Market Trends
    Table 3. Human Insulin Delivery System Market Drivers
    Table 4. Human Insulin Delivery System Market Challenges
    Table 5. Human Insulin Delivery System Market Restraints
    Table 6. Global Human Insulin Delivery System Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Human Insulin Delivery System Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Human Insulin Delivery System Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Human Insulin Delivery System Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Human Insulin Delivery System Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Human Insulin Delivery System Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Human Insulin Delivery System Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Human Insulin Delivery System Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Human Insulin Delivery System Sales Share by Manufacturer, 2017-2022
    Table 15. Global Human Insulin Delivery System Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Human Insulin Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Human Insulin Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Delivery System as of 2021)
    Table 18. Top Players of Human Insulin Delivery System in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Human Insulin Delivery System Product Type
    Table 20. Date of International Manufacturers Enter into Human Insulin Delivery System Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Human Insulin Delivery System Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Human Insulin Delivery System Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Human Insulin Delivery System Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Human Insulin Delivery System Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Human Insulin Delivery System Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Human Insulin Delivery System Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Human Insulin Delivery System Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Human Insulin Delivery System Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Human Insulin Delivery System Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Human Insulin Delivery System Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Human Insulin Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Human Insulin Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Human Insulin Delivery System Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Human Insulin Delivery System Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Human Insulin Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Human Insulin Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Human Insulin Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Human Insulin Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Human Insulin Delivery System Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Human Insulin Delivery System Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. BD Corporation Information
    Table 43. BD Description and Business Overview
    Table 44. BD Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. BD Human Insulin Delivery System Product
    Table 46. BD Recent Development
    Table 47. Novo Nordisk Corporation Information
    Table 48. Novo Nordisk Description and Business Overview
    Table 49. Novo Nordisk Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Novo Nordisk Product
    Table 51. Novo Nordisk Recent Development
    Table 52. Medtronic Corporation Information
    Table 53. Medtronic Description and Business Overview
    Table 54. Medtronic Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Medtronic Product
    Table 56. Medtronic Recent Development
    Table 57. Sanofi Corporation Information
    Table 58. Sanofi Description and Business Overview
    Table 59. Sanofi Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Sanofi Product
    Table 61. Sanofi Recent Development
    Table 62. ELI Lilly and Company Corporation Information
    Table 63. ELI Lilly and Company Description and Business Overview
    Table 64. ELI Lilly and Company Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. ELI Lilly and Company Product
    Table 66. ELI Lilly and Company Recent Development
    Table 67. Ypsomed Holding Corporation Information
    Table 68. Ypsomed Holding Description and Business Overview
    Table 69. Ypsomed Holding Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Ypsomed Holding Product
    Table 71. Ypsomed Holding Recent Development
    Table 72. Animas Corporation Corporation Information
    Table 73. Animas Corporation Description and Business Overview
    Table 74. Animas Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Animas Corporation Product
    Table 76. Animas Corporation Recent Development
    Table 77. Tandem Diabetes Care Corporation Information
    Table 78. Tandem Diabetes Care Description and Business Overview
    Table 79. Tandem Diabetes Care Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Tandem Diabetes Care Product
    Table 81. Tandem Diabetes Care Recent Development
    Table 82. Insulet Corporation Corporation Information
    Table 83. Insulet Corporation Description and Business Overview
    Table 84. Insulet Corporation Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 85. Insulet Corporation Product
    Table 86. Insulet Corporation Recent Development
    Table 87. Biocon Corporation Information
    Table 88. Biocon Description and Business Overview
    Table 89. Biocon Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 90. Biocon Product
    Table 91. Biocon Recent Development
    Table 92. Roche Corporation Information
    Table 93. Roche Description and Business Overview
    Table 94. Roche Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 95. Roche Product
    Table 96. Roche Recent Development
    Table 97. Johnson & Johnson Corporation Information
    Table 98. Johnson & Johnson Description and Business Overview
    Table 99. Johnson & Johnson Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 100. Johnson & Johnson Product
    Table 101. Johnson & Johnson Recent Development
    Table 102. Microport Corporation Information
    Table 103. Microport Description and Business Overview
    Table 104. Microport Human Insulin Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 105. Microport Product
    Table 106. Microport Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Human Insulin Delivery System Customers List
    Table 110. Human Insulin Delivery System Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Insulin Delivery System Product Picture
    Figure 2. Global Human Insulin Delivery System Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Human Insulin Delivery System Market Size 2017-2028 (US$ Million)
    Figure 4. Global Human Insulin Delivery System Sales 2017-2028 (K Units)
    Figure 5. United States Human Insulin Delivery System Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Human Insulin Delivery System Market Size 2017-2028 (US$ Million)
    Figure 7. United States Human Insulin Delivery System Sales 2017-2028 (K Units)
    Figure 8. United States Human Insulin Delivery System Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Human Insulin Delivery System Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Human Insulin Delivery System Report Years Considered
    Figure 11. Product Picture of Automatic
    Figure 12. Product Picture of Manual
    Figure 13. Global Human Insulin Delivery System Market Share by Type in 2022 & 2028
    Figure 14. Global Human Insulin Delivery System Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Human Insulin Delivery System Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Human Insulin Delivery System Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Human Insulin Delivery System Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Human Insulin Delivery System Price by Type (2017-2028) & (US$/Unit)
    Figure 19. United States Human Insulin Delivery System Market Share by Type in 2022 & 2028
    Figure 20. United States Human Insulin Delivery System Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Human Insulin Delivery System Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Human Insulin Delivery System Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Human Insulin Delivery System Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Human Insulin Delivery System Price by Type (2017-2028) & (US$/Unit)
    Figure 25. Product Picture of Hospitals
    Figure 26. Product Picture of Clinics
    Figure 27. Product Picture of Homecare
    Figure 28. Global Human Insulin Delivery System Market Share by Application in 2022 & 2028
    Figure 29. Global Human Insulin Delivery System Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Human Insulin Delivery System Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Human Insulin Delivery System Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Human Insulin Delivery System Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Human Insulin Delivery System Price by Application (2017-2028) & (US$/Unit)
    Figure 34. United States Human Insulin Delivery System Market Share by Application in 2022 & 2028
    Figure 35. United States Human Insulin Delivery System Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Human Insulin Delivery System Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Human Insulin Delivery System Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Human Insulin Delivery System Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Human Insulin Delivery System Price by Application (2017-2028) & (US$/Unit)
    Figure 40. North America Human Insulin Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Human Insulin Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Human Insulin Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Human Insulin Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Human Insulin Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Human Insulin Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Human Insulin Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Human Insulin Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Human Insulin Delivery System Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Human Insulin Delivery System Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. UAE Human Insulin Delivery System Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Human Insulin Delivery System Value Chain
    Figure 74. Human Insulin Delivery System Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed